ANO1 and cystic fibrosis: Therefore, targeting other ion channels known to also affect CF disease severity such as the sodium channel ENaC [146] or alternative ion channels TMEM16A (ANO1 [147, 148]) and SLC26A9 [149, 150] may need to be assessed to find effective therapies for all individuals with CF.